Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

77.25 -1.46 (-1.85%)

Streaming Delayed Price Updated: 12:57 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

May 22, 2025

From Edwards Lifesciences Corporation

Via Business Wire

What's going on in today's pre-market session: S&P500 movers ↗

May 20, 2025

Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.

Via Chartmill

Edwards Lifesciences Corp (NYSE:EW) - A Technical Breakout Candidate Worth Watching ↗

May 15, 2025

Edwards Lifesciences (NYSE:EW) shows strong technicals and a consolidation pattern, making it a breakout candidate. Resistance at $76.76 could signal further upside if broken.

Via Chartmill

What's Driving the Market Sentiment Around Edwards Lifesciences? ↗

May 07, 2025

Via Benzinga

P/E Ratio Insights for Edwards Lifesciences ↗

May 01, 2025

Via Benzinga

Earnings Scheduled For April 23, 2025 ↗

April 23, 2025

Via Benzinga

A Look Into Edwards Lifesciences Inc's Price Over Earnings ↗

February 26, 2025

Via Benzinga

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

May 06, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

May 01, 2025

From Edwards Lifesciences Corporation

Via Business Wire

9 Health Care Stocks Whale Activity In Today's Session ↗

April 28, 2025

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

April 24, 2025

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

Via Chartmill

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens ↗

April 24, 2025

Edwards Lifesciences raised 2025 revenue forecast after Q1 results beat EPS estimates and TMTT sales jumped 58% amid strong global demand.

Via Benzinga

What's going on in today's session: S&P500 movers ↗

April 24, 2025

Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

April 24, 2025

Via Benzinga

Thursday's pre-market session: top gainers and losers in the S&P500 index ↗

April 24, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗

April 24, 2025

U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...

Via Benzinga

Topics Government World Trade

Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat ↗

April 23, 2025

Edwards Lifesciences stock was flat late Wednesday after the medtech company beat profit views and delivered in-line sales.

Via Investor's Business Daily

Topics ETFs

Edwards Lifesciences Reports First Quarter Results

April 23, 2025

From Edwards Lifesciences Corporation

Via Business Wire

A Look at Edwards Lifesciences's Upcoming Earnings Report ↗

April 22, 2025

Via Benzinga

Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue

April 18, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Is Edwards Lifesciences Gaining or Losing Market Support? ↗

April 17, 2025

Via Benzinga

Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday? ↗

April 23, 2025

Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.

Via Benzinga

Topics Government

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

April 16, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

April 14, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

April 11, 2025

Via Benzinga

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry ↗

April 04, 2025

Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies...

Via Benzinga

Topics Government World Trade

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

March 31, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock ↗

March 28, 2025

Via Benzinga

How Is The Market Feeling About Edwards Lifesciences? ↗

March 17, 2025

Via Benzinga

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

February 25, 2025

From Edwards Lifesciences Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.